The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Warren Eric since 2022.
This trader's CIK number is 1916048.
At the time of last reporting, Warren Eric was the Chief Commercial Officer of Esperion Therapeutics, Inc.. (stock ticker symbol ESPR).
Also see all insider trading activities at Esperion Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ESPR | 0 | $0 | 2,903 | $4,445 | 0 | $0 |
| 2024 | ESPR | 0 | $0 | 5,657 | $11,893 | 0 | $0 |
| 2023 | ESPR | 0 | $0 | 7,644 | $29,495 | 0 | $0 |
| 2022 | ESPR | 1,000 | $7,460 | 1,444 | $9,204 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-17 | ESPR | Sale | 108 | .98 | 105 |
| 2025-03-18 | ESPR | Sale | 2,433 | 1.49 | 3,617 |
| 2025-02-19 | ESPR | Sale | 239 | 1.87 | 446 |
| 2025-01-17 | ESPR | Sale | 123 | 2.26 | 277 |
| 2024-12-17 | ESPR | Sale | 2,234 | 2.43 | 5,426 |
| 2024-11-19 | ESPR | Sale | 197 | 2.17 | 426 |
| 2024-10-17 | ESPR | Sale | 107 | 2.12 | 226 |
| 2024-09-17 | ESPR | Sale | 2,608 | 1.78 | 4,650 |
| 2024-08-19 | ESPR | Sale | 211 | 1.95 | 410 |
| 2024-07-17 | ESPR | Sale | 108 | 2.59 | 279 |
| 2024-05-17 | ESPR | Sale | 192 | 2.48 | 476 |
| 2023-09-20 | ESPR | Sale | 742 | 1.25 | 923 |
| 2023-08-18 | ESPR | Sale | 243 | 1.41 | 343 |
| 2023-07-19 | ESPR | Sale | 106 | 1.58 | 168 |
| 2023-06-21 | ESPR | Sale | 603 | 1.48 | 894 |
| 2023-05-17 | ESPR | Sale | 219 | 1.62 | 355 |
| 2023-04-19 | ESPR | Sale | 115 | 1.28 | 146 |
| 2023-03-17 | ESPR | Sale | 526 | 1.78 | 937 |
| 2023-03-07 | ESPR | Sale | 5,090 | 5.05 | 25,729 |
| 2022-10-18 | ESPR | Sale | 107 | 7.69 | 822 |
| 2022-09-19 | ESPR | Sale | 255 | 6.92 | 1,764 |
| 2022-08-31 | ESPR | Buy | 1,000 | 7.46 | 7,460 |
| 2022-08-17 | ESPR | Sale | 199 | 6.82 | 1,356 |
| 2022-07-19 | ESPR | Sale | 431 | 6.58 | 2,836 |
| 2022-06-17 | ESPR | Sale | 256 | 4.90 | 1,254 |
| 2022-05-17 | ESPR | Sale | 196 | 5.98 | 1,172 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Warren Eric (Chief Commercial Officer of Esperion Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.